Cash, not revenue, has become the dividing line between cannabis operators that survive and those that don't. Green Thumb Industries (OTC: GTBIF) just posted first-quarter numbers that reinforce why it's treated as the sector's steady hand: $300.2 million in revenue, up 7.4% year over year, alongside $76 million in operating cash flow, $93.5 million in normalized EBITDA, and GAAP net income of $15.4 million. In an industry still working through the wreckage of overexpansion, that combination is rare enough to warrant a closer look.
The balance sheet tells a similar story. Green Thumb ended the quarter with roughly $344.5 million in cash and $289.9 million in total debt - a manageable ratio in a business where many multi-state operators carry debt loads that dwarf their liquidity. Rather than tapping equity markets, management repurchased about 6 million shares for $33.3 million during the quarter, then added another 7.4 million shares afterward, pushing 2025 buybacks to nearly $78 million. That's a meaningful signal in a sector where dilution has been the default financing tool. Operationally, the company's retail footprint now exceeds 110 Rise dispensaries, supported by back-end systems that keep inventory, compliance logs, and wholesale menus synchronized across state lines - the kind of infrastructure that matters more than it gets credit for. Illinois remains one of the more demanding markets on that front, and operators there increasingly lean on dedicated dispensary software in Illinois to manage seed-to-sale tracking and METRC reporting without the manual errors that invite regulatory scrutiny. dispensary software in Illinois
Why Cash Flow Became the Real Scoreboard
For years, cannabis valuations leaned on top-line growth, license counts, and store openings. That approach fell apart once capital tightened. Operators that expanded aggressively under Section 280E's tax burden - which disallows standard business deductions for plant-touching companies - found themselves owing federal tax bills on income they hadn't actually banked. Add in dilutive raises and mounting debt service, and the pattern becomes familiar: revenue climbing while cash reserves quietly disappear. Green Thumb's discipline around store selection, including targeted moves into Minnesota and Texas rather than blanket expansion, reflects a management team pricing growth against actual cash generation, not market share bragging rights.
What This Means for Operators and Investors
The lesson extends past one company's balance sheet. Dispensary owners and multi-state operators evaluating expansion should treat operating cash flow, not projected revenue, as the primary underwriting metric - landlords and lenders increasingly do. Wholesale pricing pressure in mature markets isn't going away, and neither is the 280E burden, absent federal rescheduling. That leaves compliance efficiency, inventory shrinkage control, and disciplined capital allocation as the levers operators can actually pull today.
Federal reform, if it arrives, would likely lift smaller, more leveraged operators faster than an already-profitable company like Green Thumb. But that upside comes with proportional risk. Green Thumb's bet is different: build a business that works under current rules, generate real cash, and let buybacks - not equity raises - do the shareholder-friendly work. Whether that qualifies as the sector's safest position is a matter for investors to weigh, but the underlying discipline is the part every operator, regardless of size, should be paying attention to.